Mac Bohanan
Neurology · Tallahassee, FLNPI 1861017139
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by UCB, Inc. at 31.1% of the total. That places this record below the midpoint for neurology clinicians in FL, where the typical reported total is $1,698.
Across 67 payments — averaging $24.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$505
- Livanova USA, Inc.$172
- Teva Pharmaceuticals USA, Inc.$108
- Amgen$81
- Pfizer$79
- Greenwich Biosciences, Inc.$74
- plus $602 from 17 others
What the payments were for
- Food & beverage$1,53595%
- Education$875%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 20 | $505 |
| Livanova USA, Inc. | 5 | $172 |
| Teva Pharmaceuticals USA, Inc. | 2 | $108 |
| Amgen | 3 | $81 |
| Pfizer | 4 | $79 |
| Greenwich Biosciences, Inc. | 4 | $74 |
| SK Life Science, Inc. | 3 | $72 |
| Ipsen Biopharmaceuticals, Inc | 3 | $58 |
| Nevro Corp. | 2 | $55 |
| Jazz Pharmaceuticals Inc. | 3 | $54 |
| Novartis | 2 | $53 |
| AbbVie | 3 | $45 |
| Sanofi | 2 | $35 |
| AstraZeneca(2 entities) | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $30 |
| EMD Serono, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Hospira, Inc. | 1 | $23 |
| Neurelis, Inc. | 1 | $21 |
| Kedrion Biopharma, Inc. | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| NS Pharma, Inc. | 1 | $15 |
| Novocure Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS - Sentiva$105
How this compares
$1,622 in reported general payments places this provider in the 45th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 15 | $402 |
Paid to pharmacies, not to this prescriber.
Other neurology in Tallahassee
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
- Tuan VuTampa$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.